KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Net Debt Issuances and Repayments: 2009-2011

  • Jazz Pharmaceuticals' Net Debt Issuances and Repayments was N/A to $28.0 million in Q1 2011 from the same period last year, while for Mar 2011 it was $69.5 million, marking a year-over-year change of. This contributed to the annual value of $19.7 million for FY2010, which is 87.67% up from last year.
  • As of Q1 2011, Jazz Pharmaceuticals' Net Debt Issuances and Repayments stood at $28.0 million, which was up 22.83% from $22.8 million recorded in Q3 2010.
  • Over the past 5 years, Jazz Pharmaceuticals' Net Debt Issuances and Repayments peaked at $28.0 million during Q1 2011, and registered a low of $6.2 million during Q1 2009.
  • Its 3-year average for Net Debt Issuances and Repayments is $15.1 million, with a median of $10.5 million in 2010.
  • Data for Jazz Pharmaceuticals' Net Debt Issuances and Repayments shows a peak YoY soared of 181.29% (in 2010) over the last 5 years.
  • Over the past 3 years, Jazz Pharmaceuticals' Net Debt Issuances and Repayments (Quarterly) stood at $8.1 million in 2009, then spiked by 181.29% to $22.8 million in 2010, then reached $28.0 million in 2011.
  • Its Net Debt Issuances and Repayments stands at $28.0 million for Q1 2011, versus $22.8 million for Q3 2010 and $10.5 million for Q2 2010.